Federation Des Caisses Desjardins Du Quebec Actinium Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 14, 2024
SELL
$8.51 - $14.26 $11,063 - $18,538
-1,300 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$4.57 - $6.4 $5,941 - $8,320
1,300 New
1,300 $6.64 Million
Q4 2021

Aug 30, 2024
SELL
$6.01 - $8.8 $4,808 - $7,040
-800 Reduced 38.1%
1,300 $7.81 Million
Q3 2021

Aug 30, 2024
BUY
$5.76 - $9.67 $12,096 - $20,307
2,100 New
2,100 $18.6 Million

Others Institutions Holding ATNM

# of Institutions
74
Shares Held
8.31M
Call Options Held
65.2K
Put Options Held
21.7K
View Full List

About Actinium Pharmaceuticals, Inc.

ATNM Quotes by TradingView
  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $28.2M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email